Ethosomal Nanocarriers for Hydrophilic Peptide Encapsulation: Formulation Optimization, Stability, and In Vitro
Yasemin Yağan Uzuner1,2, Hakan Sevinç2,3, Zeynep Kanlidere4
1Department of Pharmaceutical Technology, Faculty of Pharmacy, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Türkiye.
Molecules (Basel, Switzerland)
|February 27, 2026
Summary
Ethosomal nanocarriers effectively encapsulate hydrolyzed collagen peptides (HCP), enhancing their stability and controlled release for anti-aging skin treatments. This formulation improves topical delivery and bioavailability of these key dermocosmetic ingredients.
Area of Science:
- Dermocosmetics and Nanotechnology
- Biomaterials Science
- Formulation Chemistry
Background:
- Hydrolyzed collagen peptides (HCP) are vital for skin hydration, elasticity, and extracellular matrix integrity in anti-aging products.
- The high hydrophilicity of HCP hinders their incorporation into lipid-based formulations and limits controlled release.
- Developing advanced delivery systems is crucial to overcome these limitations for enhanced dermocosmetic efficacy.
Purpose of the Study:
- To design and optimize ethosomal nanocarriers for improved encapsulation, stability, and controlled release of hydrophilic collagen peptides (HCP).
- To evaluate the physicochemical properties and in vitro performance of HCP-loaded ethosomes for dermocosmetic applications.
- To investigate the potential of ethosomes as a platform for enhancing the topical bioavailability of collagen peptides.
Main Methods:
- Ethosomal nanocarriers loaded with HCP were prepared using phospholipid and ethanol, optimized via high-pressure homogenization.
- Characterization included vesicle size, zeta potential, pH, long-term stability (180 days), morphology (cryo-SEM), and peptide-lipid interactions (FTIR).
- Encapsulation efficiency, skin cell cytocompatibility (HaCaT cells), and in vitro release kinetics (Franz diffusion cells) were assessed.
Main Results:
- Optimized ethosomes exhibited nanoscale size, high colloidal stability, and negative zeta potentials (-42.9 to -76.7 mV).
- Sustained encapsulation efficiency (73% after 180 days) and preserved peptide structure were confirmed, indicating effective stabilization.
- In vitro release studies showed a controlled, prolonged release profile compared to free HCP, suggesting enhanced topical bioavailability and good skin cell compatibility.
Conclusions:
- Optimized ethosomal systems effectively stabilize hydrophilic collagen peptides for anti-aging dermocosmetic applications.
- HCP-loaded ethosomes offer a promising formulation platform for bioactive preservation, enhanced stability, and controlled topical performance.
- This approach facilitates advanced collagen-based skin rejuvenation strategies with improved efficacy and delivery.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
59
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
269
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
269
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51


